Test results
| Appearance | Good · Pass |
|---|---|
| Identity | Confirmed · HPLC · Pass |
| Purity | 99.92% · HPLC · Spec ≥ 95.0% · Pass |
| Net peptide content | 5.3 mg · HPLC · Report only |
| Sterility | No growth · PCR · No growth · Pass |
| Endotoxins | 0.0975 EU/mL · USP <85> · REPORT RESULT · Pass |
| Heavy metals | Not detected · ICP-MS · As, Cd, Cr, Hg, Pb · Pass |
| Fentanyl screen | Not detected · Pass |
Batch details
| Product | CJC-1295 Drug Affinity Complex |
|---|---|
| Batch / lot | CWD02 |
| Certificate number | COA-2026-05SGPQ |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Sep 1, 2026 |
| Labeled amount | 5mg |
| Method | Purity, Identity & Quantitation (HPLC), Sterility (PCR), Endotoxin (USP <85>), Heavy Metals (ICP-MS) |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to CWD02. Every other batch of CJC-1295 Drug Affinity Complex is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of CJC-1295 Drug Affinity Complex
- Batch CWD02, tested Jul 17, 2026
- Batch #32018, tested Feb 6, 2026